RGT 1.54% 33.0¢ argent biopharma limited

Next announcement?, page-16

  1. 4,321 Posts.
    lightbulb Created with Sketch. 487
    From my perspective, why would MXC need to apply for a growing and manufacturing licence in Australia?
    They are in the process of finalising the PANAX licence which allow them to utilise 1000M indoor growing and extraction facilities. They also have the 5000M outdoor growing field in Slovakia as well.
    They are also searching for a growing facility in south America. Australian law is too strict and we seem to be well behind other developed countries.

    Once medical cannabis is fully legalised in Australia then MXC is able to sell CBD to the Australian market. Keep in mind there is a big market in the US. Some Asian countries starts to explore into medical cannabis as well.
    Companies nowadays have their operations overseas where labour is cheaper, law is less strict etc.
    PANAX acquisition is our key milestone. Let wait until the end of this month. News is imminent.
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
33.0¢
Change
0.005(1.54%)
Mkt cap ! $15.97M
Open High Low Value Volume
32.5¢ 34.5¢ 32.0¢ $5.411K 16.32K

Buyers (Bids)

No. Vol. Price($)
1 1666 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
36.0¢ 600 1
View Market Depth
Last trade - 15.43pm 18/09/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.